Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
4
result was found. Results that relate to
ZHANG Wenjing
Efgartigimod alfa in the treatment of generalized myasthenia gravis: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(10):1156-1163.
12226 times
2425 times
HUANG Gerile
LI Yujie
ZHANG Wenjing
GUO Hao
Efgartigimod alfa
Myasthenia gravis
Rapid health technology assessment
Efficaey
Safety
Economy
Details
Dorzagliatin in the treatment of type 2 diabetes：a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(4):448-455.
19372 times
3611 times
LI Yujie
ZHANG Wenjing
YANG Hongxin
GUO Hao
Dorzagliatin
Type 2 diabetes mellitus
Rapid health technology assessment
Efficacy
Safety
Economy
Details
Mepolizumab for refractory chronic rhinosinusitis with nasal polyps: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(2):192-199.
6578 times
1117 times
GU Shilong
ZHANG Wenjing
GUO Hao
Mepolizumab
Refractory chronic rhinosinusitis with nasal polyps
Effectiveness
safety
Cost-effectiveness
Details
Meta-analysis of efficacy and safety of pertuzumab biosimilars versus original drug in the treatment of patients with HER2-positive breast cancer
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):810-817.
1053 times
333 times
GU Shilong
ZHANG Wenjing
GUO Hao
Pertuzumab
Biosimilars
Original drug
HER2
Breast cancer
Efficacy
Safety
Meta-analysis
Details
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University